JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

JMP Securities analyst Mitchell Germain maintained a Hold rating on The RMR Group (RMR – Research Report) today. The company’s shares closed ...

JMP Securities maintained its Market Perform rating on Apollo Global Management (NYSE:APO) shares without setting a new price ...

JMP Securities maintained a bullish stance on Confluent Inc (NASDAQ:CFLT), reiterating a Market Outperform rating and a ...

Mr. Cooper Group Inc. (NASDAQ:COOP – Get Free Report) was the target of unusually large options trading on Wednesday. Traders acquired 10,613 call options on the stock. This is an increase of ...

PJT Partners (NYSE:PJT – Get Free Report) had its price objective boosted by equities researchers at Keefe, Bruyette & Woods from $152.00 to $177.00 in a report issued on Wednesday,Benzinga reports.

Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...

Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...

Google parent Alphabet Inc. has been downgraded to market perform from market outperform by JMP Securities, with the analyst firm highlighting the potential impact of the company’s antitrust battle.